These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22020042)

  • 1. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
    Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
    Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
    Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
    BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
    Haberler C
    Am J Surg Pathol; 2012 Dec; 36(12):1903; author reply 1903-1904. PubMed ID: 22992696
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
    Judkins AR; Mauger J; Ht A; Rorke LB; Biegel JA
    Am J Surg Pathol; 2004 May; 28(5):644-50. PubMed ID: 15105654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature.
    Krishnan C; Vogel H; Perry A
    Hum Pathol; 2014 Jan; 45(1):185-8. PubMed ID: 24034858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma.
    Judkins AR; Burger PC; Hamilton RL; Kleinschmidt-DeMasters B; Perry A; Pomeroy SL; Rosenblum MK; Yachnis AT; Zhou H; Rorke LB; Biegel JA
    J Neuropathol Exp Neurol; 2005 May; 64(5):391-7. PubMed ID: 15892296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.
    Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C
    Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
    Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
    Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.
    Biegel JA; Fogelgren B; Zhou JY; James CD; Janss AJ; Allen JC; Zagzag D; Raffel C; Rorke LB
    Clin Cancer Res; 2000 Jul; 6(7):2759-63. PubMed ID: 10914721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical teratoid/rhabdoid tumor of the pineal region in an adult.
    Takei H; Adesina AM; Mehta V; Powell SZ; Langford LA
    J Neurosurg; 2010 Aug; 113(2):374-9. PubMed ID: 19911885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells.
    Vu-Han TL; Frühwald MC; Hasselblatt M; Kerl K; Nagel I; Obser T; Oyen F; Siebert R; Schneppenheim R
    Cancer Genet; 2014 Sep; 207(9):390-7. PubMed ID: 25016934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.